Transdermal Drug Delivery System Market

Transdermal Drug Delivery System Market - Global Market Share, Trends, Analysis and Forecast, 2023-2032
Frequently asked questions about this report

The global transdermal drug delivery system market is geared to grow at a CAGR of 6.3% from 2023 to 2032.

Increase in the demand for drug self-administration by patients with long-term ailments is among the primary growth drivers for global transdermal drug delivery systems market.

The high cost of transdermal patches when compared to other conventional treatment options and poor penetration in under developed regions will limit the market growth for Transdermal Drug Delivery System.

Transdermal drug delivery system market size was estimated to be US$ 5.5 billion in 2021.

3M, Mylan, AdhexPharma, DuPont, Endo International, Lubrizol Corporation, Novartis AG, Purdue Pharma L.P., and others are among the global leaders in Transdermal Drug Delivery System Market.

The pain management category is expected to have the greatest share of the market in transdermal drug delivery system products. One of the primary factors driving the segment's growth in the global market is the increased use of opioid medicine patches in pain treatment, particularly among cancer patients.

North America dominated the transdermal drug delivery system devices market until now, and this dominance is expected to remain at the top spot throughout the forecast period.